Catherine Skari
-
Jan- 2022 -27 January
-
27 January
-
27 January
-
13 JanuaryNews
What’s New In Clinical Trials For Thalassaemia/Sickle Cell Disease Drugs And Therapies?
Many pharmaceutical companies are making remarkable progress in their research into candidate treatments for these diseases and 2022 is expected…
Read More » -
7 JanuaryNews
SCD Drug Oxbryta Receives CHMP Positive Opinion For Approval In The EU
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending…
Read More » -
Dec- 2021 -22 DecemberTIF News
THALIA2018-2021 | Europe Is Seeing A Surge In Thalassaemia, Project Results Show
“Although thalassemia has always been endemic in Europe, especially in southern European countries such as Cyprus, Greece and Italy, the…
Read More » -
21 December
-
21 DecemberNews
TIF Article: COVID-19 Pandemic Exacerbated Existing Problems With Thalassaemia Care
The article discusses how the COVID-19 pandemic has magnified challenges in thalassaemia care worldwide and underscores TIF’s activities throughout the…
Read More » -
Jun- 2019 -12 JunePatients’ stories
FROM PUMP TO PILL by Chanapa Tantibanchachai
Winner Story #1 – International Thalassaemia Day 2018 ”As I reflect on my past, present and future as a…
Read More » -
Aug- 2022 -3 AugustNews
NEW PUBLICATION | Short Guide For the Management of TDT (2nd Edition)
The 4th edition of the original full-length Guidelines, published in June 2022, includes a full review of the evidence supporting…
Read More »
